High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
暂无分享,去创建一个
T. Hassanein | P. Kwo | E. Gane | J. Kort | D. Wyles | Stanley Wang | F. Mensa | J. Lalezari | F. Poordad | T. Ng | Armen Asatryan | B. Maliakkal | Ran Liu | H. Aguilar | Chih‐Wei Lin | A. Asatryan